SCI Pharmtech Inc
TWSE:4119
US |
VAALCO Energy Inc
NYSE:EGY
|
Energy
|
|
US |
A
|
Alpha Metallurgical Resources Inc
NYSE:AMR
|
Metals & Mining
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
CN |
Daqo New Energy Corp
NYSE:DQ
|
Semiconductors
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
Snap Inc
NYSE:SNAP
|
Media
|
|
US |
PBF Energy Inc
NYSE:PBF
|
Energy
|
|
US |
Vir Biotechnology Inc
NASDAQ:VIR
|
Biotechnology
|
|
US |
Target Hospitality Corp
NASDAQ:TH
|
Hotels, Restaurants & Leisure
|
|
UK |
Ferroglobe PLC
NASDAQ:GSM
|
Metals & Mining
|
|
US |
R C M Technologies Inc
NASDAQ:RCMT
|
Professional Services
|
|
US |
A
|
Assertio Holdings Inc
NASDAQ:ASRT
|
Pharmaceuticals
|
US |
Apple Inc
NASDAQ:AAPL
|
Technology
|
|
US |
NVIDIA Corp
NASDAQ:NVDA
|
Semiconductors
|
|
US |
Clearfield Inc
NASDAQ:CLFD
|
Communications
|
|
US |
Enphase Energy Inc
NASDAQ:ENPH
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
86.4
100
|
Price Target |
|
We'll email you a reminder when the closing price reaches TWD.
Choose the stock you wish to monitor with a price alert.
VAALCO Energy Inc
NYSE:EGY
|
US | |
A
|
Alpha Metallurgical Resources Inc
NYSE:AMR
|
US |
Nike Inc
NYSE:NKE
|
US | |
Daqo New Energy Corp
NYSE:DQ
|
CN | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
Snap Inc
NYSE:SNAP
|
US | |
PBF Energy Inc
NYSE:PBF
|
US | |
Vir Biotechnology Inc
NASDAQ:VIR
|
US | |
Target Hospitality Corp
NASDAQ:TH
|
US | |
Ferroglobe PLC
NASDAQ:GSM
|
UK | |
R C M Technologies Inc
NASDAQ:RCMT
|
US | |
A
|
Assertio Holdings Inc
NASDAQ:ASRT
|
US |
Apple Inc
NASDAQ:AAPL
|
US | |
NVIDIA Corp
NASDAQ:NVDA
|
US | |
Clearfield Inc
NASDAQ:CLFD
|
US | |
Enphase Energy Inc
NASDAQ:ENPH
|
US |
This alert will be permanently deleted.
SCI Pharmtech Inc
Net Income (Common)
SCI Pharmtech Inc
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Net Income (Common)
NT$138.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-4%
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Net Income (Common)
NT$1.1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
4%
|
|
Formosa Laboratories Inc
TWSE:4746
|
Net Income (Common)
NT$255.9m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
||
ScinoPharm Taiwan Ltd
TWSE:1789
|
Net Income (Common)
NT$403m
|
CAGR 3-Years
15%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-7%
|
||
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Net Income (Common)
NT$4B
|
CAGR 3-Years
42%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
||
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Net Income (Common)
NT$854.1m
|
CAGR 3-Years
10%
|
CAGR 5-Years
17%
|
CAGR 10-Years
11%
|
SCI Pharmtech Inc
Glance View
SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
See Also
What is SCI Pharmtech Inc's Net Income (Common)?
Net Income (Common)
138.5m
TWD
Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Net Income (Common) amounts to 138.5m TWD.
What is SCI Pharmtech Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-4%
Over the last year, the Net Income (Common) growth was -65%.